Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
NCT04047264 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-02-12
Summary
This clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of intraoperative microdialysis during neurosurgery for central nervous system malignancies. A biomarker is a measurable indicator of the severity or presence of disease state. Information collected in this study may help doctors to develop new strategies to better diagnose, monitor, and treat brain tumors.
Conditions
- Glioma
- Glioblastoma
- Metastatic Malignant Neoplasm in the Brain
Interventions
- PROCEDURE
-
Microdialysis
Undergo microdialysis
- PROCEDURE
-
Magnetic Resonance Imaging
Undergo MRI
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH - lead OTHER
Principal Investigators
-
Terence C Burns, MD, PhD · Mayo Clinic in Rochester
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2027-09-01
- Completion
- 2027-09-01
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
NCT07301268 ·Status: RECRUITING ·Phase: PHASE2
-
Radiosurgery Before Surgery for the Treatment of Brain Metastases
NCT04895592 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
O(6)-Benzylguanine in Treating Patients With Malignant Glioma
NCT00002971 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression
NCT06828341 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
NCT03493932 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
NCT04691960 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Carmustine in Treating Patients With Recurrent Malignant Glioma
NCT00004028 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant Chemoradiation for Resectable Glioblastoma
NCT04209790 ·Status: TERMINATED ·Phase: PHASE2
-
Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
NCT00305864 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
NCT00112866 ·Status: TERMINATED ·Phase: PHASE2
-
Neurocognitive Decline in Patients With Brain Metastases
NCT03508752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor
NCT02784054 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
NCT00005637 ·Status: COMPLETED ·Phase: PHASE1
-
Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain
NCT00003348 ·Status: COMPLETED ·Phase: PHASE1
-
Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients
NCT00576446 ·Status: COMPLETED ·Phase: PHASE1
-
Patient-derived Glioma Stem Cell Organoids
NCT04868396 ·Status: ACTIVE_NOT_RECRUITING
-
Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis
NCT04870645 ·Status: COMPLETED ·Phase: NA
-
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
NCT04132843 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
NCT00019578 ·Status: COMPLETED ·Phase: PHASE1
-
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
NCT04608812 ·Status: TERMINATED ·Phase: PHASE1
-
Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
NCT00645385 ·Status: WITHDRAWN
-
Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
NCT02302235 ·Status: COMPLETED ·Phase: PHASE2
-
Electrochemotherapy as a Palliative Treatment for Brain Metastases
NCT01322100 ·Status: TERMINATED ·Phase: PHASE1
-
Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases
NCT00814463 ·Status: TERMINATED ·Phase: PHASE2
-
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
NCT00253669 ·Status: COMPLETED